# A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants

> **NCT07020988** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 55 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Staccato Alprazolam
- **DRUG:** Midazolam
- **DRUG:** Diazepam

## Key facts

- **NCT ID:** NCT07020988
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-12
- **Primary completion:** 2026-01-06
- **Final completion:** 2026-01-21
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07020988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07020988, "A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07020988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*